Login to Your Account



With $11M, Syntekabio will advance bioinformatics and AI platforms

By Elise Mak
Staff Writer

Wednesday, May 16, 2018

HONG KONG – South Korean bioinformatics company Syntekabio Inc. pocketed $11.2 million in a series B financing to advance two of it core platforms in bioinformatics and AI-driven drug discovery to speed up drug development process.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription